Evidence map›Paper›PMID 28070534›Full record

ArticleReports of biochemistry & molecular biology2016

Design and Construction of a Cloning Vector Containing the

Atieh Yaghoubi, Ehsan Aryan, Hosna Zare, Shadi Alami, Roghayeh Teimourpour, Zahra Meshkat

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Reports of biochemistry & molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Atieh YaghoubiAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Ehsan AryanAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Hosna ZareAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Shadi AlamiAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Roghayeh TeimourpourDepartment of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Zahra MeshkatAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mashhad University of Medical Sciences · IRArdabil University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) is a major cause of death worldwide. Finding an effective vaccine against TB is the best way to control it. Several vaccines against this disease have been developed but none are completely protective. The aim of this study was to design and construct a cloning vector containing the

methodsFirst, an

resultsA 435 bp

conclusionIn this study, the cloning vector pcDNA3.1(+), containing a 435-bp

Indexed as

CloningDNA vaccinehspXMycobacterium tuberculosis

Identifiers

PMID28070534
PMCPMC5214683
OpenAlexW2548261470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.